Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)
NCT02262611 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 266
Last updated 2014-10-13
Summary
Study to obtain long-term data on effects, safety and tolerability in routine medical practice and to investigate the potential of telmisartan to prevent secondary organ damage
Conditions
Interventions
- DRUG
-
Micardis®
- DRUG
-
MicardisPlus®
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-31
- Primary Completion
- 2005-12-31
More Related Trials
-
Micardis® in Patients With Essential Hypertension
NCT02187705 ·Status: COMPLETED
-
Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension
NCT02242383 ·Status: COMPLETED
-
Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients
NCT00904371 ·Status: COMPLETED
-
Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus
NCT02242825 ·Status: COMPLETED
-
Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)
NCT02262637 ·Status: COMPLETED
-
Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With Hypertension
NCT02242357 ·Status: COMPLETED
-
Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure
NCT02242864 ·Status: COMPLETED
-
A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)
NCT02242396 ·Status: COMPLETED
-
Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension
NCT00659607 ·Status: COMPLETED
-
Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension
NCT00257491 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension
NCT02242370 ·Status: COMPLETED ·Phase: PHASE4
-
Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial
NCT00147264 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy Volunteers
NCT02259816 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise
NCT00946829 ·Status: COMPLETED
-
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives
NCT00539487 ·Status: COMPLETED
-
Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities
NCT00242814 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients
NCT01108809 ·Status: COMPLETED
-
Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters
NCT00615108 ·Status: COMPLETED
-
Assessment of Compliance With Antihypertensive Telmisartan Therapy
NCT00470886 ·Status: COMPLETED
-
Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male Subjects
NCT02262572 ·Status: COMPLETED ·Phase: PHASE1
-
J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation
NCT00659581 ·Status: COMPLETED
-
Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
NCT00281580 ·Status: COMPLETED ·Phase: PHASE3
-
Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension
NCT03267329 ·Status: COMPLETED ·Phase: PHASE4
-
A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers
NCT05223101 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension
NCT02177422 ·Status: COMPLETED ·Phase: PHASE3